Evidence map›Paper›PMID 42796578›Full record

ArticleMolecules (Basel, Switzerland)2026

Selenium Nanoparticles: Novel Synthesis, Characterization, Polymer Functionalization, and Cytotoxicity In Vitro.

Dhireshan Singh, Aliscia Nicole Daniels, Mario Ariatti, Moganavelli Singh

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dhireshan SinghNano-Gene and Drug Delivery Group, Discipline of Biochemistry, University of KwaZulu-Natal, Private Bag X54001, Durban 4000, South Africa.
Aliscia Nicole DanielsNano-Gene and Drug Delivery Group, Discipline of Biochemistry, University of KwaZulu-Natal, Private Bag X54001, Durban 4000, South Africa.
Mario AriattiNano-Gene and Drug Delivery Group, Discipline of Biochemistry, University of KwaZulu-Natal, Private Bag X54001, Durban 4000, South Africa.
Moganavelli SinghNano-Gene and Drug Delivery Group, Discipline of Biochemistry, University of KwaZulu-Natal, Private Bag X54001, Durban 4000, South Africa.ORCID 0000-0002-9985-6567

Funding

National Research Foundation 129263; 120455
6 · The paper itself

Abstract

backgroundNanotechnology, a multidisciplinary science, has diverse applications in biology, physics, and medicine. SeNPs have only recently been explored. Understanding how modifications to SeNPs affect toxicity is beneficial for therapeutic applications. This study involves a novel one-pot chemical synthesis of SeNPs using biodegradable precursors, sodium selenite and ascorbic acid, at predetermined molar ratios, followed by polymer modification.

resultsAll SeNPs were spherical with favorable sizes (<114 nm) and polydispersity indices (PDI < 0.4). Functionalization improved the zeta potential of the SeNPs (-34.4 to 91.1 mV), together with a smaller size and increased PDI. Cytotoxicity was size-, cell-, dose-, and time-dependent. Functionalized SeNPs showed good cell viability at low concentrations, with toxicity at higher concentrations compared to the unmodified SeNPs. SeNPs synthesized using excess sodium selenite exhibited enhanced toxicity, particularly in neuroblastoma cells. SeNPs induced a significant increase in reactive oxygen species, with G1/G0 cell cycle arrest and apoptosis in human embryonic kidney cells, and necrosis and apoptosis in neuroblastoma and cervical carcinoma cells.

conclusionThe physicochemical and toxicity profiles of SeNPs depend on precursor molar ratios and polymer concentration. Hence, studying the released ions and the polymer-core association will enable the personalized synthesis of SeNPs to achieve the desired therapeutic outcomes.

Indexed as

NanoparticlesPolymersSeleniumApoptosisCell Line, TumorCell SurvivalHumansParticle SizeReactive Oxygen SpeciesPolymersReactive Oxygen SpeciesSeleniumchitosancytotoxicityoxidative stresspolyethylene glycolselenium nanoparticles

Identifiers

PMID42796578
PMCPMC13610086

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.